KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,579 | +6.5% | 20,814 | -34.2% | 0.00% | 0.0% |
| Q1 2023 | $340,435 | -3.8% | 31,639 | +34.0% | 0.00% | 0.0% |
| Q4 2022 | $353,737 | +35.5% | 23,614 | +16.0% | 0.00% | 0.0% |
| Q3 2022 | $261,000 | +107.1% | 20,361 | +89.6% | 0.00% | – |
| Q4 2021 | $126,000 | -22.7% | 10,740 | -25.6% | 0.00% | – |
| Q3 2021 | $163,000 | -20.1% | 14,439 | -1.7% | 0.00% | – |
| Q2 2021 | $204,000 | -31.1% | 14,689 | -8.3% | 0.00% | -100.0% |
| Q1 2021 | $296,000 | +678.9% | 16,017 | +628.0% | 0.00% | – |
| Q4 2020 | $38,000 | +15.2% | 2,200 | 0.0% | 0.00% | – |
| Q3 2020 | $33,000 | -41.1% | 2,200 | 0.0% | 0.00% | – |
| Q2 2020 | $56,000 | +64.7% | 2,200 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
| Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
| Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
| AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
| Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
| RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
| ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
| Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |